Literature DB >> 2812514

Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment.

K A Rudolphi1, M Keil, J Fastbom, B B Fredholm.   

Abstract

We have used the fact that long-term caffeine treatment upregulates the adenosine receptors, to examine the role of adenosine in ischaemia. Four-week oral treatment with caffeine (0.2% in drinking water) caused a significant (10-17%) increase in the binding of the adenosine A1-receptor ligand [3H]cyclohexyl-adenosine (CHA) to several brain regions, including the hippocampal CA1 area, in Mongolian gerbils. Animals subjected to such treatment exhibited significantly less neuronal damage in the CA1 region following 5 min bilateral carotid occlusion than did control animals (50% of the caffeine-treated animals showed no damage at all compared to 11% in the control group). Our findings provide further evidence for a protective role of endogenous adenosine during ischaemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812514     DOI: 10.1016/0304-3940(89)90112-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  24 in total

1.  Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum.

Authors:  Xuesong Chen; Xun Lan; Ian Roche; Rugao Liu; Jonathan D Geiger
Journal:  J Neurochem       Date:  2008-09-20       Impact factor: 5.372

2.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

3.  Caffeine exposure ameliorates acute ischemic cell death in avian developing retina.

Authors:  D Pereira-Figueiredo; R Brito; D S M Araújo; A A Nascimento; E S B Lyra; A M S S Cheibub; A D Pereira Netto; A L M Ventura; R Paes-de-Carvalho; K C Calaza
Journal:  Purinergic Signal       Date:  2020-02-20       Impact factor: 3.765

Review 4.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

5.  Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

Authors:  G P Matherne; J Linden; A M Byford; N S Gauthier; J P Headrick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

6.  Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers - results of German National Health Surveys from 1984 to 1999.

Authors:  Yong Du; Hans-Ulrich Melchert; Hildtraud Knopf; Marianne Braemer-Hauth; Barbara Gerding; Ellen Pabel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  The role of adenosine in Alzheimer's disease.

Authors:  Anisur Rahman
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 8.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

9.  Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.

Authors:  D K Von Lubitz; R C Lin; N Melman; X D Ji; M F Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-04-21       Impact factor: 4.432

10.  Regulation of cerebrospinal fluid production by caffeine consumption.

Authors:  Myoung-Eun Han; Hak-Jin Kim; Young-Suk Lee; Dong-Hyun Kim; Joo-Taek Choi; Chul-Sik Pan; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  BMC Neurosci       Date:  2009-09-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.